Cellular events involved in the sensitization of etoposide-resistant cells by inhibitors of calcium-calmodulin-dependent processes. Role for effects on apoptosis, DNA cleavable complex, and phosphorylation

Biochemical Pharmacology
K KawamuraR Ganapathi

Abstract

Inhibitors of calcium-calmodulin-dependent processes, 1-[N,O-bis(1,5-isoquinolinesulfonyl)-N-methyl-L-tyrosyl]-4-piperazine KN-62 and trifluoperazine (TFP), at non-cytotoxic concentrations (2 and 5 microM, respectively) enhanced etoposide (VP-16) cytotoxicity in Adriamycin-resistant (HL-60/ADR0.05) cells (3- to > 50-fold). In contrast to TFP, the inhibitor KN-62 was able to reverse resistance in HL-60/ADR0.05 cells at VP-16 concentrations that produced equivalent cytotoxicity in sensitive (HL-60/S) cells. Unlike TFP, the cellular accumulation of VP-16 in the presence of KN-62 was enhanced 1.5- to 2-fold in HL-60/S (MDR1 -ve) and HL-60/ADR0.05 (MDR1 +ve) cells. To achieve equivalent cytotoxicity, levels of VP-16 in the resistant cells were > 4-fold lower in the presence of KN-62 compared with treatment with VP-16 alone. The sensitizing effects of both KN-62 and TFP were due to enhancement (2- to 4-fold) of VP-16-induced topoisomerase II (TOPO II)-mediated DNA cleavable complex formation, and depletion of the 170 kDa (alpha) TOPO II isoform. The DNA damage induced by VP-16 in the presence of KN-62 or TFP resulted in the rapid induction of apoptosis and depletion of cells in "S" phase of the cell cycle. Both 5 microM TFP and 2 mic...Continue Reading

References

Sep 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·H TowbinJ Gordon
Jan 1, 1989·Annual Review of Biochemistry·J A Endicott, V Ling
Sep 26, 1988·FEBS Letters·M Y HurwitzA R Means
Mar 1, 1984·Cancer Treatment Reviews·R Osieka
Oct 13, 1995·Biochemical and Biophysical Research Communications·N H ObataH Hidaka
Jan 1, 1993·Cytotechnology·J M Ford, W N Hait
Jan 1, 1994·Annual Review of Pharmacology and Toxicology·A Y Chen, L F Liu
Jan 1, 1993·Advances in Enzyme Regulation·W T BeckM Chen
Jan 1, 1993·Advances in Cancer Research·K V ChinM M Gottesman
Oct 20, 2009·Journal of the American Academy of Dermatology·Khalid A Al JohaniStefano Fedele

❮ Previous
Next ❯

Citations

Jun 16, 2001·Cell Biology International·M SalidoG M Roomans
Feb 1, 2012·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Noriyuki TakaiHisashi Narahara
Jun 18, 2002·Cancer Letters·Noriyuki TakaiIsao Miyakawa
Apr 13, 2000·Bioorganic & Medicinal Chemistry Letters·P G BaraldiF di Virgilio
Jul 31, 1998·Leukemia & Lymphoma·S H KaufmannJ E Karp
Aug 13, 2011·Molecular Cancer Therapeutics·Naoki MineTakumi Kawabe

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis